We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ABLD market cap is 5.62M. The company's latest EPS is EUR 0.0269 and P/E is 104.09.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 8.78M | 7.12M |
| Operating Income | -70k | -91k | -103k | 1.08M | -164k |
| Net Income | -63k | -89k | 258k | 1.11M | 54k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 7.21M | 2.38M | 2.71M | 15.41M | 14.9M |
| Total Liabilities | 118k | 18k | 94k | 8.65M | 8.14M |
| Total Equity | 7.09M | 2.36M | 2.62M | 6.75M | 6.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -278k | N/A | -57k | N/A | N/A |
| Investing | N/A | N/A | 400k | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 5.62M |
| Price to Earnings Ratio | 104.09 |
| Price to Sales Ratio | 0.79 |
| Price to Cash Ratio | 2.53 |
| Price to Book Ratio | 0.83 |
| Dividend Yield | - |
| Shares Outstanding | 2.01M |
| Average Volume (1 week) | 6 |
| Average Volume (1 Month) | 4 |
| 52 Week Change | -71.13% |
| 52 Week High | 9.70 |
| 52 Week Low | 2.70 |
| Spread (Intraday) | 0.06 (2.1%) |
| Company Name | ABL Diagnostics |
| Address |
72 c, route de thionville paris, paris 57140 |
| Website | https://www.abldiagnostics.com |
| Industry | lessors of real property,nec (6519) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
